Video interview with Narendranath Epperla, MD who discusses progression of disease within 24 months as a predictor of survival in indolent lymphomas.
Video interview with Narendranath Epperla, MD who discusses progression of disease within 24 months as a predictor of survival in indolent lymphomas.